RecombiMAb human IgG1 (LALA-PG) isotype control, anti-respiratory syncytial virus

Catalog #CP161
Clone:
Palivizumab-CP161
Reactivities:
Virus

$217.00 - $5,910.00

Choose an Option...
  • 100 mg - $5,910.00
  • 50 mg - $4,229.00
  • 25 mg - $2,942.00
  • 5 mg - $843.00
  • 1 mg - $217.00
  • Custom Amount (Quotes Only)
In stock
Only %1 left

Product Details

This human IgG1 isotype control antibody reacts with respiratory syncytial virus and has low or no specific binding to any human sample. The P329G substitution combined with L234A and L235A (LALA-PG) has been shown to decrease effector functions by disrupting the Fc/Fcγ receptor interface.

Specifications

Isotype Human IgG1
Recommended Dilution Buffer InVivoPure pH 7.0 Dilution Buffer
Mutations L234A, L235A, P329G (LALA-PG)
Formulation PBS, pH 7.0
Contains no stabilizers or preservatives
Endotoxin <1EU/mg (<0.001EU/μg)
Determined by LAL gel clotting assay
Purity >95%
Determined by SDS-PAGE
Sterility 0.2 µm filtration
Production Purified from CHO cell supernatant
Purification Protein G
Molecular Weight 150 kDa
Storage The antibody solution should be stored at the stock concentration at 4°C. Do not freeze.